Rheumatoid Arthritis Diagnosis and Management

Introduction to Rheumatoid Arthritis

The American College of Rheumatology recommends that a positive rheumatoid factor (RF) requires immediate clinical correlation with joint examination and complementary testing, as most positive results in unselected populations are false positives, but when combined with clinical synovitis, RF significantly increases diagnostic confidence for rheumatoid arthritis 1, 2

The American College of Rheumatology and European League Against Rheumatism (ACR/EULAR) classification criteria assign points for joint involvement, serology, acute phase reactants, and duration, with a total score of ≥6/10 indicating definite RA 1
Joint involvement is scored as follows: 1 large joint = 0 points, 2-10 large joints = 1 point, 1-3 small joints = 2 points, 4-10 small joints = 3 points, >10 joints = 5 points 1
Serology is scored as follows: negative RF and ACPA = 0 points, low positive RF or ACPA = 2 points, high positive RF or ACPA = 3 points 1

The American College of Rheumatology recommends ordering anti-CCP antibodies immediately, as this test has superior specificity (90%) compared to RF (70%) and provides critical diagnostic and prognostic information 1, 2, 3
Inflammatory markers, such as CRP, should be ordered, as they are more reliable and not age-dependent compared to ESR 1, 3

The American College of Rheumatology recommends obtaining bilateral hand, wrist, and foot X-rays to assess for erosions, which predict RA diagnosis and disease persistence 1, 3
Ultrasound with Power Doppler is superior to clinical examination for detecting subclinical synovitis and predicts disease progression 1, 3

The American College of Rheumatology recommends referring patients to rheumatology within 6 weeks of symptom onset if RF is positive with clinical synovitis 3
Methotrexate 15 mg weekly should be started as first-line DMARD, with a plan to escalate to 20-25 mg weekly 1, 3
Target remission (SDAI ≤3.3) or low disease activity (SDAI ≤11) with reassessment every 4-6 weeks 1, 3

RF positivity, especially high-titer or persistent positivity, predicts more aggressive disease with higher frequency of joint destruction, increased extra-articular manifestations, and lower remission rates 2
The American College of Rheumatology notes that RF positivity is associated with worse functional capacity and quality of life 2